EP1786417A4 - Neue polymorphe von azabicyclohexan - Google Patents

Neue polymorphe von azabicyclohexan

Info

Publication number
EP1786417A4
EP1786417A4 EP05785506A EP05785506A EP1786417A4 EP 1786417 A4 EP1786417 A4 EP 1786417A4 EP 05785506 A EP05785506 A EP 05785506A EP 05785506 A EP05785506 A EP 05785506A EP 1786417 A4 EP1786417 A4 EP 1786417A4
Authority
EP
European Patent Office
Prior art keywords
azabicyclohexane
novel polymorphs
polymorphs
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05785506A
Other languages
English (en)
French (fr)
Other versions
EP1786417A2 (de
Inventor
Eric J Hagen
Kevin Halloran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DOV Pharmaceutical Inc
Original Assignee
DOV Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DOV Pharmaceutical Inc filed Critical DOV Pharmaceutical Inc
Publication of EP1786417A2 publication Critical patent/EP1786417A2/de
Publication of EP1786417A4 publication Critical patent/EP1786417A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
EP05785506A 2004-08-18 2005-08-17 Neue polymorphe von azabicyclohexan Withdrawn EP1786417A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92074804A 2004-08-18 2004-08-18
PCT/US2005/029420 WO2006023659A2 (en) 2004-08-18 2005-08-17 Novel polymorphs of azabicyclohexane

Publications (2)

Publication Number Publication Date
EP1786417A2 EP1786417A2 (de) 2007-05-23
EP1786417A4 true EP1786417A4 (de) 2009-05-20

Family

ID=35968183

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05785506A Withdrawn EP1786417A4 (de) 2004-08-18 2005-08-17 Neue polymorphe von azabicyclohexan

Country Status (14)

Country Link
EP (1) EP1786417A4 (de)
JP (1) JP2008510715A (de)
KR (3) KR20070054208A (de)
CN (1) CN101052393A (de)
AU (1) AU2005277351A1 (de)
BR (1) BRPI0515193A (de)
CA (1) CA2619817A1 (de)
IL (1) IL181185A (de)
MX (1) MX2007001827A (de)
NO (1) NO20071372L (de)
NZ (1) NZ589033A (de)
RU (1) RU2007109817A (de)
WO (1) WO2006023659A2 (de)
ZA (1) ZA200701570B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070043100A1 (en) 2005-08-16 2007-02-22 Hagen Eric J Novel polymorphs of azabicyclohexane
EP1915146A4 (de) 2005-07-27 2010-06-02 Dov Pharmaceutical Inc Neuartige 1-aryl-3-azabicyclo[3.1.0]hexane. herstellung und verwendung zur behandlung von neuropsychiatrischen erkrankungen
US20080045725A1 (en) * 2006-04-28 2008-02-21 Murry Jerry A Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane
US8138377B2 (en) 2006-11-07 2012-03-20 Dov Pharmaceutical, Inc. Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use
US9133159B2 (en) 2007-06-06 2015-09-15 Neurovance, Inc. 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments
US20120258994A1 (en) * 2010-12-03 2012-10-11 Mckinney Anthony Alexander Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
WO2014182279A1 (en) * 2013-05-07 2014-11-13 Euthymics Bioscience, Inc. Use of (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane to treat addictive and alcohol-related disorders
KR101567003B1 (ko) 2013-12-27 2015-11-06 경희대학교 산학협력단 골편 고정장치 및 골편 절단을 위한 드릴 어셈블리
CA2989431C (en) 2015-06-17 2023-08-29 Franklin Bymaster Crystalline compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435419A (en) * 1981-07-01 1984-03-06 American Cyanamid Company Method of treating depression using azabicyclohexanes
US6372919B1 (en) * 2001-01-11 2002-04-16 Dov Pharmaceutical, Inc. (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CAIRA M R: "CRYSTALLINE POLYMORPHISM OF ORGANIC COMPOUNDS", TOPICS IN CURRENT CHEMISTRY, SPRINGER, BERLIN, DE, vol. 198, 1 January 1998 (1998-01-01), pages 163 - 208, XP001156954, ISSN: 0340-1022, ISBN: 978-3-540-36760-4, DOI: 10.1007/3-540-69178-2_5 *
SKOLNICK P ET AL: "Antidepressant-like actions of DOV 21,947: A triple reuptake inhibitor", EUROPEAN JOURNAL OF PHARMACOLOGY, ELSEVIER BV, NL, vol. 461, no. 2-3, 14 February 2003 (2003-02-14), pages 99 - 104, XP002306753, ISSN: 0014-2999 *

Also Published As

Publication number Publication date
KR20130108489A (ko) 2013-10-02
CN101052393A (zh) 2007-10-10
AU2005277351A1 (en) 2006-03-02
RU2007109817A (ru) 2008-09-27
EP1786417A2 (de) 2007-05-23
CA2619817A1 (en) 2006-03-02
MX2007001827A (es) 2007-04-23
NZ589033A (en) 2012-06-29
KR20130004370A (ko) 2013-01-09
BRPI0515193A (pt) 2008-07-08
NO20071372L (no) 2007-05-18
IL181185A0 (en) 2007-07-04
KR20070054208A (ko) 2007-05-28
JP2008510715A (ja) 2008-04-10
IL181185A (en) 2012-10-31
WO2006023659A3 (en) 2006-12-07
WO2006023659A2 (en) 2006-03-02
ZA200701570B (en) 2008-08-27

Similar Documents

Publication Publication Date Title
EP1778618A4 (de) Synthese von triethylenetetraminen
IL181587A0 (en) Production of ??-abeta
PL1802579T3 (pl) Pochodne 3-aryloaminopirydynowe
IL182580A0 (en) Polymorphic forms of 6-[2-
EP1718638A4 (de) Neue verbindungen
GB0400812D0 (en) Novel compounds
EP1711484A4 (de) Synthese von cyanoiminobenzimidazolen
IL181185A0 (en) Novel polymorphs of azabicyclohexane
EP1804582A4 (de) Polymorphe formen von tadalafil
GB0402140D0 (en) Novel compounds
IL185029A0 (en) Preparation of tadalafil intermediates
GB0402496D0 (en) Novel compounds
EP1805132A4 (de) Neue verbindungen
EP1796793A4 (de) Neue verbindungen
GB0402357D0 (en) Novel compounds
IL181164A0 (en) Novel uses of 2-phenyl-substituted imidazotriazinone derivatives
SI1812422T1 (sl) Kristalna oblika irbesartana
ZA200703630B (en) Polymorphs of sarsapogenin
GB0402812D0 (en) Novel compounds
GB0402355D0 (en) Novel compounds
GB0402356D0 (en) Novel compounds
IL178184A0 (en) Synthesis of pyrrole-2-carbonitriles
GB0402380D0 (en) Novel compounds
SI1709057T1 (sl) Sinteza spongozina
ZA200508325B (en) Manufacture of kerbstones

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070308

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK YU

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090422

17Q First examination report despatched

Effective date: 20090629

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20120724